Who Buys Oseltamivir from India — 314 Importers Behind a $122.6M Market
India's oseltamivir import market is served by 314 active buyers who collectively imported $122.6M across 2,149 shipments. EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) leads with a 8.0% market share, followed by NATCO PHARMA (CANADA) INC and STRIDES PHARMA INC. The top 5 buyers together control 31.3% of total import value, reflecting a moderately competitive buyer landscape.
Oseltamivir buyer data — 314 importers · $122.6M market · 2,149 shipmentsTransData Nexus · Indian Customs Data
Top Oseltamivir Importers — Ranked by Import Value
EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) is the leading oseltamivir importer from India, holding a 8.0% share of the $122.6M market across 2,149 shipments from 314 buyers. The top 5 buyers — EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), NATCO PHARMA (CANADA) INC (CANADA), STRIDES PHARMA INC (UNITED STATES), AMNEAL PHARMACEUTICALS, LLC (KY) (UNITED STATES), MACLEODS PHARMACEUTICAL LIMITED LLC (UKRAINE) — collectively control 31.3% of total import value.
Top Oseltamivir Buyers & Importers
Ranked by import value · 314 active buyers · Indian Customs (DGFT) data
Mar 2026
Top Oseltamivir Buyers & Importers — Ranked by Import Value. 314 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Oseltamivir — and from which countries?
Flow of Oseltamivir exports from India: each country's share and the named importers behind the numbers
Oseltamivir — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 86.3% of global Oseltamivir imports — led by United States (59.0%) with a total trade value of $122.6M across 2,149 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $72.4M through 220 shipments. This represents a market share of 59.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• EVERSANA LIFE SCIENCE SERVICES - $9.8M (13.5% of country's total business)
• STRIDES PHARMA INC - $8.9M (12.3% of country's total business)
• AMNEAL PHARMACEUTICALS, LLC (KY) - $5.3M (7.4% of country's total business)
• J. KNIPPER & COMPANY - $2.1M (2.9% of country's total business)
• XXANTXXPHAXXA UXX INX - $1.8M (2.5% of country's total business)
• Rest of United States's importers - $44.5M (61.5% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $329.0K, indicating premium pricing strategy compared to the market average of $57.1K.
United States is a key market for Oseltamivir imports, representing 59.0% of total trade value.
The importation of Oseltamivir from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like EVERSANA LIFE SCIENCE SERVICES (United States) and J. KNIPPER & COMPANY (United States) fall into this category. They procure large volumes to supply pharmacies, hospitals, and healthcare providers, often placing substantial orders during flu seasons to meet heightened demand.
Contract Manufacturers: Companies such as NATCO PHARMA (CANADA) INC (Canada) and STRIDES PHARMA INC (United States) import Oseltamivir for further processing or packaging before distribution. Their procurement is typically steady, aligning with production schedules and market demand forecasts.
Re-exporters: Entities like NANJING JULY PHARMACEUTICAL TECHNOLOGY (China) and CHONGQING PHARMACEUTICAL (GROUP) CO (China) import Oseltamivir with the intent to export to other markets. Their purchasing patterns are influenced by global demand fluctuations and trade agreements.
Government Procurement Agencies: Organizations such as MACLEODS PHARMACEUTICAL LIMITED LLC (Ukraine) often engage in tender-based purchasing to supply public health institutions. Their orders are typically large and placed periodically, aligning with national healthcare initiatives and stockpile requirements.
The top five importing countries have distinct regulatory frameworks for Oseltamivir:
1. United States:
Regulatory Authority: Food and Drug Administration (FDA).
Import Registration Process: Importers must ensure that Oseltamivir is FDA-approved. The process involves submitting a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), including comprehensive data on safety, efficacy, and manufacturing quality.
Estimated Timeline: The approval process can take 10 to 12 months, depending on the completeness of the application and FDA review timelines.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are generally duty-free, but importers should verify current tariffs with U.S. Customs and Border Protection.
2. China:
Regulatory Authority: National Medical Products Administration (NMPA).
The demand for Oseltamivir across importing countries is influenced by several key factors:
Disease Prevalence: Influenza outbreaks significantly drive Oseltamivir demand. For instance, during the 2024-2025 flu season, the United States reported over 35 million flu cases, leading to increased antiviral prescriptions.
Government Healthcare Programs: Many countries have national health programs that stockpile antivirals like Oseltamivir to manage seasonal flu outbreaks and potential pandemics.
Universal Health Coverage Expansion: Countries expanding healthcare access often include essential medicines like Oseltamivir in their formularies, increasing demand.
WHO Essential Medicines List Procurement: Oseltamivir's inclusion in the WHO Model List of Essential Medicines encourages its procurement by member states, ensuring availability during influenza seasons.
Tender-Based Purchasing: Government and large healthcare organizations frequently use tender systems to procure Oseltamivir, leading to bulk purchasing and stable demand.
Common Questions — Oseltamivir Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest oseltamivir buyer importing from India?
Based on import volume and value, EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) leads with $9.8M in imports and a 8.0% market share — the highest of any single oseltamivir importer. NATCO PHARMA (CANADA) INC (CANADA) and STRIDES PHARMA INC (UNITED STATES) are the next largest buyers.
QHow many companies buy oseltamivir from India?
There are 314 active oseltamivir buyers importing from India, with a combined market of $122.6M across 2,149 shipments to 79 countries. The top 5 buyers hold 31.3% of total import value, while the remaining 309 buyers handle the other 68.7%.
QWhich countries import the most oseltamivir from India?
The top importing countries for oseltamivir from India are United States (59.0%), China (10.7%), Canada (10.6%), Ukraine (4.1%), Philippines (1.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of oseltamivir, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
The importation of Oseltamivir from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like EVERSANA LIFE SCIENCE SERVICES (United States) and J. KNIPPER & COMPANY (United States) fall into this category. They procure large volumes to supply pharmacies, hospitals, and healthcare providers, often placing substantial orders during flu seasons to meet heightened demand.
Contract Manufacturers: Companies such as NATCO PHARMA (CANADA) INC (Canada) and STRIDES PHARMA INC (United States) import Oseltamivir for further processing or packaging before distribution. Their procurement is typically steady, aligning with production schedules and market demand forecasts.
Re-exporters: Entities like NANJING JULY PHARMACEUTICAL TECHNOLOGY (China) and CHONGQING PHARMACEUTICAL (GROUP) CO (China) import Oseltamivir with the intent to export to other markets. Their purchasing patterns are influenced by global demand fluctuations and trade agreements.
Government Procurement Agencies: Organizations such as MACLEODS PHARMACEUTICAL LIMITED LLC (Ukraine) often engage in tender-based purchasing to supply public health institutions. Their orders are typically large and placed periodically, aligning with national healthcare initiatives and stockpile requirements.
The top five importing countries have distinct regulatory frameworks for Oseltamivir:
1. United States:
Regulatory Authority: Food and Drug Administration (FDA).
Import Registration Process: Importers must ensure that Oseltamivir is FDA-approved. The process involves submitting a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), including comprehensive data on safety, efficacy, and manufacturing quality.
Estimated Timeline: The approval process can take 10 to 12 months, depending on the completeness of the application and FDA review timelines.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are generally duty-free, but importers should verify current tariffs with U.S. Customs and Border Protection.
2. China:
Regulatory Authority: National Medical Products Administration (NMPA).
The demand for Oseltamivir across importing countries is influenced by several key factors:
Disease Prevalence: Influenza outbreaks significantly drive Oseltamivir demand. For instance, during the 2024-2025 flu season, the United States reported over 35 million flu cases, leading to increased antiviral prescriptions.
Government Healthcare Programs: Many countries have national health programs that stockpile antivirals like Oseltamivir to manage seasonal flu outbreaks and potential pandemics.
Universal Health Coverage Expansion: Countries expanding healthcare access often include essential medicines like Oseltamivir in their formularies, increasing demand.
WHO Essential Medicines List Procurement: Oseltamivir's inclusion in the WHO Model List of Essential Medicines encourages its procurement by member states, ensuring availability during influenza seasons.
Tender-Based Purchasing: Government and large healthcare organizations frequently use tender systems to procure Oseltamivir, leading to bulk purchasing and stable demand.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
2China
China emerges as the second largest importing country, achieving a total trade value of $13.1M through 64 shipments. This represents a market share of 10.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: China has a diverse importer base, with their top importers including:
• NANJING JULY PHARMACEUTICAL TECHNOL - $2.0M (15.2% of country's total business)
• CHONGQING PHARMACEUTICAL (GROUP) CO - $1.8M (13.5% of country's total business)
• CHONGQING PHARMACEUTICAL GROUP - $1.3M (9.8% of country's total business)
• CHONGQING PHARMACEUTICAL(GROUP) CO. - $1.2M (9.3% of country's total business)
Key Insight: China demonstrates strong market positioning with an average shipment value of $205.2K, indicating premium pricing strategy compared to the market average of $57.1K.
China is a key market for Oseltamivir imports, representing 10.7% of total trade value.
Primary Market
Secondary Market
3Canada
Canada emerges as the third largest importing country, achieving a total trade value of $13.0M through 75 shipments. This represents a market share of 10.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• NATCO PHARMA (CANADA) INC - $9.5M (73.4% of country's total business)
• NATCO PHARMA CANADA INC - $1.6M (12.7% of country's total business)
• NATCO PHARMA (CANADA)INC - $1.3M (9.8% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $172.8K, indicating premium pricing strategy compared to the market average of $57.1K.
Canada is a key market for Oseltamivir imports, representing 10.6% of total trade value.
Primary Market
Secondary Market
4Ukraine
Ukraine emerges as the fourth largest importing country, achieving a total trade value of $5.1M through 6 shipments. This represents a market share of 4.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Ukraine has a diverse importer base, with their top importers including:
• MACLEODS PHARMACEUTICAL LIMITED LLC - $4.9M (95.9% of country's total business)
Key Insight: Ukraine demonstrates strong market positioning with an average shipment value of $844.2K, indicating premium pricing strategy compared to the market average of $57.1K.
Ukraine is a key market for Oseltamivir imports, representing 4.1% of total trade value.
Primary Market
Secondary Market
5Philippines
Philippines emerges as the fifth largest importing country, achieving a total trade value of $2.2M through 0 shipments. This represents a market share of 1.8% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Philippines demonstrates strong market positioning with an average shipment value of $2.2M, indicating premium pricing strategy compared to the market average of $57.1K.
Philippines is a key market for Oseltamivir imports, representing 1.8% of total trade value.
Primary Market
Secondary Market
Each segment's procurement strategy is tailored to their operational needs, market dynamics, and regulatory environments, ensuring a consistent supply of Oseltamivir to meet public health demands.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Importers must obtain an Imported Drug License (IDL) by submitting an application that includes clinical trial data, manufacturing details, and quality standards.
Estimated Timeline: The registration process typically takes 12 to 18 months, subject to NMPA review schedules.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are subject to a 5% import duty, but rates may vary; importers should consult the latest customs tariff schedules.
3. Canada:
Regulatory Authority: Health Canada.
Import Registration Process: Importers must obtain a Drug Identification Number (DIN) by submitting a New Drug Submission (NDS) or Abbreviated New Drug Submission (ANDS), providing evidence of safety, efficacy, and quality.
Estimated Timeline: The approval process can take 12 to 18 months, depending on the submission's complexity and Health Canada's review timelines.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are generally duty-free, but importers should confirm with the Canada Border Services Agency.
4. Ukraine:
Regulatory Authority: State Service of Ukraine on Medicines and Drugs Control (SMDC).
Import Registration Process: Importers must register the drug by submitting an application that includes clinical data, manufacturing information, and quality standards.
Estimated Timeline: The registration process typically takes 12 to 15 months, subject to SMDC review schedules.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are subject to a 10% import duty; importers should verify current rates with Ukrainian customs authorities.
5. Philippines:
Regulatory Authority: Food and Drug Administration Philippines (FDA Philippines).
Import Registration Process: Importers must obtain a Certificate of Product Registration (CPR) by submitting an application that includes clinical trial data, manufacturing details, and quality standards.
Estimated Timeline: The registration process can take 6 to 12 months, depending on the completeness of the application and FDA Philippines' review timelines.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are generally duty-free, but importers should confirm with the Bureau of Customs.
Importers are advised to consult the respective regulatory authorities and customs agencies for the most current information, as regulations and tariffs are subject to change.
TransData Nexus Research · Government and regulatory sourcesMar 2026
With 314 buyers across 79 countries, the market for Oseltamivir remains robust, driven by public health initiatives and the necessity to manage influenza outbreaks effectively.
TransData Nexus Research · Government and regulatory sourcesMar 2026
QWhat is the average import order value for oseltamivir from India?
The average import transaction value for oseltamivir from India is $57.1K, with an average unit price of $3.50 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Each segment's procurement strategy is tailored to their operational needs, market dynamics, and regulatory environments, ensuring a consistent supply of Oseltamivir to meet public health demands.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Importers must obtain an Imported Drug License (IDL) by submitting an application that includes clinical trial data, manufacturing details, and quality standards.
Estimated Timeline: The registration process typically takes 12 to 18 months, subject to NMPA review schedules.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are subject to a 5% import duty, but rates may vary; importers should consult the latest customs tariff schedules.
3. Canada:
Regulatory Authority: Health Canada.
Import Registration Process: Importers must obtain a Drug Identification Number (DIN) by submitting a New Drug Submission (NDS) or Abbreviated New Drug Submission (ANDS), providing evidence of safety, efficacy, and quality.
Estimated Timeline: The approval process can take 12 to 18 months, depending on the submission's complexity and Health Canada's review timelines.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are generally duty-free, but importers should confirm with the Canada Border Services Agency.
4. Ukraine:
Regulatory Authority: State Service of Ukraine on Medicines and Drugs Control (SMDC).
Import Registration Process: Importers must register the drug by submitting an application that includes clinical data, manufacturing information, and quality standards.
Estimated Timeline: The registration process typically takes 12 to 15 months, subject to SMDC review schedules.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are subject to a 10% import duty; importers should verify current rates with Ukrainian customs authorities.
5. Philippines:
Regulatory Authority: Food and Drug Administration Philippines (FDA Philippines).
Import Registration Process: Importers must obtain a Certificate of Product Registration (CPR) by submitting an application that includes clinical trial data, manufacturing details, and quality standards.
Estimated Timeline: The registration process can take 6 to 12 months, depending on the completeness of the application and FDA Philippines' review timelines.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are generally duty-free, but importers should confirm with the Bureau of Customs.
Importers are advised to consult the respective regulatory authorities and customs agencies for the most current information, as regulations and tariffs are subject to change.
TransData Nexus Research · Government and regulatory sourcesMar 2026
With 314 buyers across 79 countries, the market for Oseltamivir remains robust, driven by public health initiatives and the necessity to manage influenza outbreaks effectively.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 314 global importers of Oseltamivir identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 2,149 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 79 destination countries with market share per buyer calculated from capped values.
